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S U M M A R Y
We report a case of cryptococcal immune reconstitution inﬂammatory syndrome affecting the lungs, and
10 months later the cervical lymph nodes, in the absence of cryptococcal meningitis, in advanced HIV
infection. Our report demonstrates the organ-speciﬁcity of the timing of the inﬂammatory response and
illustrates the organ-speciﬁc interplay of immunity and infection in cryptococcal disease.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Cryptococcal immune reconstitution inﬂammatory syndrome
(IRIS) is a monophasic illness that presents as ‘paradoxical IRIS’ in
patients with diagnosed cryptococcal disease, or as ‘unmasking
IRIS’ in patients who present with a ﬁrst episode of cryptococcal
disease after starting antiretroviral therapy (ART).1 It usually
affects the meninges, manifesting itself as cryptococcal meningitis.
Here, we report a patient who developed a multiphasic and
multifocal cryptococcal disease over a period of 2 years, involving
lungs and lymph nodes, without meningeal involvement.* Corresponding author. Tel.: +49 30 130 20 8129; fax: +49 30 130 20 3938.
E-mail address: juri.katchanov@charite.de (J. Katchanov).
1201-9712       2013 The Authors. Published by Elsevier Ltd on behalf of International So
http://dx.doi.org/10.1016/j.ijid.2013.08.0121.1. Case report
A 40-year old patient with known HIV infection presented with
a 2-month history of cough and malaise. He had not been on ART
for 10 months. His CD4 count was 80/ml (normal range 700–1200/
ml). Thoracic computed tomography (CT) showed a consolidation
in the left upper lobe. Bronchoalveolar lavage (BAL) and blood
cultures did not grow any microorganisms. Tests for Pneumocystis
jirovecii (immunoﬂuorescence and PCR) and Mycobacterium
tuberculosis (PCR and cultures) were negative. The cryptococcal
antigen titer in serum was 1:128. Lumbar puncture including India
ink examination and fungal cultures, revealed no pathological
ﬁndings. The patient was started on antifungal therapy with
liposomal amphotericin B. He improved and discharged himself on
day 14 against medical advice. He continued on ART consisting of
tenofovir/emtricitabine, darunavir/ritonavir, and maraviroc, as
well as ﬂuconazole.
The patient presented 12 months later with a 2-month history
of cough, intermittent fevers, night sweats, and malaise. The CD4
count was 320/ml and his viral load was undetectable. A thoracic
CT scan revealed a round central pulmonary nodule in the left lung,
which was initially considered to represent a pulmonaryciety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 1. (A) Enhanced CT showing a central nodular mass in the left lung located between the upper lobe bronchus and the segmental bronchus. (B) Lung specimen showing
three granulomas in the alveolar tissue surrounded by thickened pleura (hematoxylin and eosin stain, original magniﬁcation 25); inset: high-power ﬁeld examination of the
granuloma, showing numerous yeast-like structures (periodic acid-Schiff (PAS) stain, original magniﬁcation 400). (C) Contrast-enhanced CT scan of the neck at the level of
thyroid gland, showing enlarged left cervical lymph nodes with ring-enhancement and central areas of low attenuation necrosis. (D) Left cervical lymph node histology
showing numerous encapsulated yeast-like structures on PAS stain (original magniﬁcation 400). (E) Time course of clinical manifestations, cryptococcal antigen titer in
serum (CrAG), antiretroviral therapy (ART), and CD4 cell count (in cells/ml).
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cultures and lumbar puncture were negative. The cryptococcal
antigen titer in serum was 1:16. Thoracoscopic resection of the
lesion was performed. Histological examinations revealed multiple
granulomas with numerous periodic acid-Schiff (PAS)-positive
yeast-like structures (Figure 1B), but there was no growth of any
bacterial or fungal microorganisms. The patient was started on
combination therapy of liposomal amphotericin B and 5-ﬂucyto-
sine for 14 days, as well as prednisolone 0.5 mg/kg bodyweight
with rash tapering. He was discharged clinically well on oral
ﬂuconazole (400 mg daily). Four months later the patient stopped
his ART and antifungal therapy. He re-started ART after a 2-month
break. Three months after the re-introduction of ART he presented
with a painful swelling on his neck. His temperature was 38.2 8C.
There was a tender left-sided supraclavicular mass. A contrast-
enhanced CT scan of the neck showed extensive left cervical
supraclavicular lymphadenopathy (Figure 1C). Fine-needle biopsy
revealed necrotic areas with yeast-like structures identiﬁed on PAS
stain (Figure 1D). Fungal cultures from the lymph node biopsy
were negative. The cryptococcal antigen titer in serum was 1:2. His
CD4 cell count was 297/ml and his viral load was undetectable.
A 2-week course of liposomal amphotericin B and 5-ﬂucytosine
with prednisolone 1 mg/kg bodyweight was repeated, followed byﬂuconazole maintenance therapy with rash tapering of predniso-
lone. At the 4-week follow-up, there was a reduction in the
swelling both on clinical examination and CT imaging. At the 4-
month follow-up, there was complete resolution of the clinical and
radiological lesions. Retrospective DNA extraction from formalin-
ﬁxed parafﬁn embedded (FFPE) tissue samples from the lung and
cervical lymph nodes revealed fungal DNA in the lung but not in
the lymph nodes. The fungal DNA was identiﬁed as Cryptococcus
neoformans var. grubii by a microarray developed for Cryptococcus
neoformans and Cryptococcus gattii, which is based on the IGS
region of rDNA.
2. Discussion
After presumed cryptococcal pneumonia, our patient suffered
from two episodes of inﬂammatory manifestations of cryptococcal
disease: ﬁrst, a pulmonary nodule, and 10 months later, a cervical
lymphadenitis. Pulmonary nodules and cervical lymphadenitis are
rare but documented presentations of cryptococcal immune
reconstitution syndrome.1,2 According to the recently proposed
deﬁnition of cryptococcal IRIS, both episodes can be classiﬁed as
‘paradoxical IRIS’:3 they occurred after initiation of ART, the
cryptococcal cultures were negative, and there was a signiﬁcant
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presumed cryptococcal pneumonia to 1:16 at the time of
pulmonary nodule and then 1:2 at the time of cervical
lymphadenitis). At the same time, the second episode of immune
reconstitution ‘unmasked’ the Cryptococcus-associated disease at
a different site.
To our knowledge, this is the ﬁrst report of a multiphasic and
multifocal cryptococcal IRIS in the absence of cryptococcal
meningitis. Our case illustrates how persisting cryptococcal
antigen triggers an inﬂammatory response every time the immune
system is reconstituted by ART (Figure 1E). Interestingly, during
the ﬁrst episode of inﬂammation targeted against cryptococcal
antigen in the lung, there was no inﬂammation of cervical lymph
nodes. The latter occurred only during the second attack of IRIS.
The dissociation of both events raises the question if the quality of
the immune response following immune reconstitution differs
between lung and lymph nodes. Of note, the most common form of
Cryptococcus IRIS, cryptococcal meningitis, commonly occurs
early after initiation of ART in a time frame where intrinsic
control of an exaggerated immune response is limited.4 In contrast,
Cryptococcus IRIS in the lymph nodes usually represents a delayed
reaction.2
According to the current theory, the key event of IRIS is a failure
to clear antigen during the early phase of immune recovery,
followed by an uncontained response to this persistent antigen
during immune reconstitution.5 IRIS is increasingly being consid-
ered not just an acute event, but a developing process with distinctimmunological phases that evolve pathologically long before an
IRIS event occurs clinically.5 Our cases support this notion of IRIS as
a prolonged immunological process with ‘ﬂare-ups’ triggered by
ART-associated improvement in immune status. Our patient
beneﬁted from anti-inﬂammatory therapy with steroids. However,
with each episode we started antifungal treatment, as an active
infection with Cryptococcus could not be ruled out pending culture
results.
In conclusion, the organ-speciﬁc inﬂammatory response in
cryptococcal IRIS has not yet been addressed in the literature.
Further prospective studies with special emphasis on delayed IRIS
affecting the lungs and lymph nodes are needed.
Conﬂict of interest: The authors report no conﬂict of interest.
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